Reversible severe hereditary hemochromatotic cardiomyopathy

Canadian Journal of Cardiology

Volumn 13, Issue 4, 1997, Pages 391-394

  Madani, Tariq Ahmed A ^a,b   Bormanis, Janis ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cardiomyopathy; Deferoxamine mesylate; Hemochromatosis; Phlebotomy; Stroke

Indexed keywords

CHELATING AGENT; DEFEROXAMINE MESYLATE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; HEMOCHROMATOSIS; HUMAN; MALE; PHLEBOTOMY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CARDIOMYOPATHIES; DEFEROXAMINE; HEMOCHROMATOSIS; HUMANS; MALE; PHLEBOTOMY; SEVERITY OF ILLNESS INDEX; SIDEROPHORES;

EID: 8244258014     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Krumholz HM. Congestive heart failure in a middle-aged man. Hosp Pract 1990;25:63-6.
2. Rivers J, Garraby P, Robinson W, Murphy A. Reversible cardiac dysfunction in hemochromatosis. Am Heart J 1987;113:216-7.
3. Dabestani A, Child J, Henze E, et al. Primary hemochromatosis: anatomic and physiologic characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol 1984;54:153-9.
4. Candell-Riera J, Lu L, Seres L, et al. Cardiac hemochromatosis. beneficial effects of iron removal therapy; an echocardiograghic study. Am J Cardiol 1983;52:824-9.
5. Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis; morphologic and clinical improvement following venesection. Am J Med 1981;70:1275-9
6. Skinner C, Kenmure ACF. Hemochromatosis presenting as congestive cardiomyopathy and responding to venesection. Br Heart J 1973;35:466-8
7. Easley RM, Schreiner BF, Yu PN. Reversible cardiomyopathy associated with hemochromatosis. N Engl J Med 1972;287:466-88.
8. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. Medicine (Baltimore) 1955;34:381-430.
9. Neiderau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary haemochromatosis. N Engl J Med 1985;313:1256-62.
10. Buja LM, Roberts WC. Iron in the heart, etiology and clinical significance. Am J Med 1971;51:209-21.
11. Rahko PS, Salemi R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol 1986;8:436-40.
12. MacDonald RA, Mallory GK. Hemochromatosis and hemosiderosis; study of 211 autopsied cases. Arch Intern Med 1960;105:686-700.
13. Keschner HW. The heart in hemochromatosis. South Med J 1951;44:927-30.
14. Powell LW, Isselbacher KJ. Hemochromatosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994:2069-73.